The Medical Letter on Drugs and Therapeutics
FROM
ISSUE 1473
ISSUE 1473
July 20, 2015
Issue 1473
Subscribers: Log in to read full issue. Not a subscriber? Subscribe or purchase issue.
Aptensio XR - Another Long-Acting Methylphenidate for ADHD
July 20, 2015 (Issue: 1473)
The FDA has approved Aptensio XR (Rhodes), an extended-release formulation of methylphenidate hydrochloride, for treatment of attention-deficit/hyperactivity disorder (ADHD). The Aptensio XR capsules contain multilayer beads designed to provide both...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.